Evidence map›Paper›PMID 34324280›Full record

SynthesisImmunity, inflammation and disease2021

The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence.

SeyedAhmad SeyedAlinaghi, Amirali Karimi, Mehrzad MohsseniPour, Alireza Barzegary, Seyed Peyman Mirghaderi, Amirata Fakhfouri, Solmaz Saeidi, Armin Razi, Hengameh Mojdeganlou, Marcarious M Tantuoyir and 3 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Immunity, inflammation and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 8 pooled it
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 8 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Hearing loss and COVID-19: an umbrella review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Review
  11. Article
  12. Exploring the Relationship Between Comorbidities and Prolonged Viral Shedding in COVID-19: A Cycle Threshold Value-Based Investigation.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 5 countries.

SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-3210-7905
Amirali KarimiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mehrzad MohsseniPourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Alireza BarzegarySchool of Medicine, Islamic Azad University, Tehran, Iran.
Seyed Peyman MirghaderiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Amirata FakhfouriSchool of Medicine, Islamic Azad University, Tehran, Iran.
Solmaz SaeidiDepartment of Nursing, University of Medical Sciences, Khalkhal, Iran.
Armin RaziInternal Medicine Department, Tehran University of Medical Sciences, Tehran, Iran.
Hengameh MojdeganlouDepartment of Pathology, Urmia University of Medical Sciences, Urmia, Iran.
Marcarious M TantuoyirSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Amir Masoud AfsahiDepartment of Radiology, University of California, San Diego (UCSD), San Diego, California, USA.
Esmaeil MehraeenDepartment of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.ORCID 0000-0003-4108-2973
Omid DadrasDepartment of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tehran University of Medical Sciences · IRIranian Institute for Health Sciences Research · IRIslamic Azad University, Tehran · IRIran University of Medical Sciences · IRKyoto University · JPLorestan University of Medical Sciences · IRUniversity of California San Diego · USUniversity of Ghana · GHUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with chronic underlying diseases are more susceptible to coronavirus disease 2019 (COVID-19) complications. Recent studies showed people living with HIV (PLWH) are not at greater risk than the general population. Few studies have reviewed the impacts of COVID-19 on PLWH. The purpose of this systematic review was to investigate the impact of COVID-19 on patients infected with HIV.

methodsWe executed a systematic search using four databases of PubMed, Scopus, Science Direct, and Web of Science and screened the records in two steps based on their title/abstract and full text. This study follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to elevate the validity and reliability of its results.

resultsWe reviewed 36 studies. The patients' age was above 20 years in all studies. In almost all studies, the inflammatory parameters were reported high. In most of the studies, all HIV patients completely recovered from the COVID 19 infection. Although CD4 count was not recorded in all studies, the minimum level was reported as 12 cells/µl.

conclusionBased on the current review, we concluded that HIV patients at advanced stages (3 or 4) of the disease, whose CD4 counts are low, may show less severe COVID-19 infection symptoms. Similarly, Interference can reduce the severity of immune reactions and subsequent cytokine storms and consequently mitigate the symptoms. Therefore, in most of the studies, the majority of HIV patients showed no severe symptoms and completely recovered from COVID 19 infection.

Indexed as

COVID-19HIV InfectionsAdultHumansReproducibility of ResultsSARS-CoV-2Young Adultclinical outcomeCOVID-19HIV/AIDSSARS-CoV-2severity

Identifiers

PMID34324280
PMCPMC8426924
OpenAlexW3184873572

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.